Immune checkpoint inhibitor‐induced diarrhea: Clinicopathological study of 11 patients

We reviewed the records of patients with immune checkpoint inhibitor (ICI)‐induced diarrhea during 2015 to 2019. ICI included nivolumab and ipilimumab. There were 11 patients with ICI‐induced diarrhea aged 46–81 years (median, 63 years). On colonoscopy, four patients appeared normal, whereas loss of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Digestive endoscopy 2020-05, Vol.32 (4), p.616-620
Hauptverfasser:	Yanai, Shunichi, Nakamura, Shotaro, Kawasaki, Keisuke, Toya, Yosuke, Akasaka, Risaburo, Oizumi, Tomofumi, Ishida, Kazuyuki, Sugai, Tamotsu, Matsumoto, Takayuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over colitis Colitis - chemically induced Colitis - diagnosis Colitis - therapy Colonoscopy diarrhea Diarrhea - chemically induced Diarrhea - pathology Diarrhea - therapy Female Gastroenterology & Hepatology Humans Immune Checkpoint Inhibitors - adverse effects immune‐related adverse event ipilimumab Ipilimumab - adverse effects Life Sciences & Biomedicine Male Middle Aged nivolumab Nivolumab - adverse effects Retrospective Studies Science & Technology Surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!